Can-Fite Biopharma Ltd Sponsore (CANF) Financials
CANF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 9.2 million | 3.9 million |
| 2023-06-30 | 11.0 million | 4.2 million |
| 2023-03-31 | 13.5 million | 5.0 million |
| 2022-12-31 | 9.3 million | 4.8 million |
CANF Free Cash Flow and Stock based compensation
No data available :(
CANF Net Income
No data available :(
CANF Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 7.9 million | - | 51000 |
| 2023-06-30 | 9.6 million | - | 66000 |
| 2023-03-31 | 12.4 million | - | 48000 |
| 2022-12-31 | 8.0 million | - | 62000 |
CANF Shares Outstanding
CANF Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.3 million | 762000 | - |
| 2023-06-30 | - | 1.4 million | 624000 | - |
| 2023-03-31 | - | 2.1 million | 847000 | - |
| 2022-12-31 | 9038 | 2.5 million | 826000 | - |
CANF Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 196000 | - |
| 2023-06-30 | 196000 | - |
| 2023-03-31 | 196000 | - |
| 2022-12-31 | 197000 | - |
CANF
Price: $1.98
52 week price:
Earnings Per Share: -1.48 USD
P/E Ratio: -1.44
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 29900
Market Capitalization: 14.4 million